The Series A financing was led by Par Equity to support international expansion and product development.
"Securing this investment allows us to scale our impact across healthcare and life sciences, with a focus on easing the burden of paediatric clinical trials. While legislation like RACE, SPCs, and the ODA has increased study numbers, specialist paediatric knowledge is still lacking in the industry. This has led to lower recruitment, adherence and trial completion rates compared to adult research. Little Journey is uniquely positioned to fill this expertise gap and tackle these challenges to advance global paediatric medicine. With the backing of Par Equity, Mercia Ventures, Octopus Ventures, and our wider investor network, we’re redefining how paediatric clinical trials are run and putting families at the heart of them."
The pre-seed round was led by YZR Capital to support clinical trials and platform development for eating disorder care.
"The widening gap between the need for care and available resources, along with the lack of personalised treatment options, urgently requires a radical rethink of how eating disorder care is provided. Our goal is to revolutionise care pathways, providing tools that empower clinicians and deliver meaningful results. We aim to keep people out of hospital and enable better long-term recovery while saving costs for the healthcare system. Univa’s platform will augment the overwhelmed clinical workforce by providing evidence-based tools to reach more patients and families, enabling earlier intervention, improved monitoring, and faster recovery."
Calm/Storm Ventures led the pre-seed financing, which will fund product development and artificial intelligence integration.
"Doshi meets young adults where they already are, helps and supports them to take the right (financial) decisions. We are confident that the founders, Daniel and Jaco, may be able to catch the new generation where even Neobanks fail."
The financing round was led by Frontline Ventures to support team expansion and technology development.
"Our mental healthcare industry is in crisis. The demand for services is growing, while the supply of skilled professionals is dwindling. Our mission at Nolea Health is to create a revolutionary platform that will change how healthcare providers find talent and healthcare professionals find jobs. With our innovative approach, we believe we can make a real difference in this area and successfully address the urgent issue of staff shortages."
The seed round was backed by investors including Firstminute Capital, Presight Capital, and Seedcamp.
"Traditional clinical research companies are dinosaurs. Taking part in a COVID vaccine trial was like stepping into a time machine. This was one of the best funded trials in history but research was done on pen and paper and participants had to go into hospital at the height of the pandemic to fill out forms. We founded Lindus Health to make it easier for patients to participate in research, and accelerate the development of new treatments."
